Also, C-reactive protein value has been described in literature as negative prognostic parameter in advanced cancer and in ovarian cancer (16, 25) The aim of this study is to describe the Italian reality about chemotherapy in the end of life in a cohort of ovarian cancer patients, and to identify factors associated with the probability of receiving chemotherapy in this period. The gene discussed is CRP; the disease is ovarian carcinoma.